Who owns LIMINATUS PHARMA LLC?
- Ticker: LIMNW
- CUSIP Number: 53271x116
Tip: Access positions for across all investors
Analyze quarterly positions in Liminatus Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Liminatus Pharma stock
Who bought or sold LIMINATUS PHARMA LLC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Clear Street | 806k | $193k | 100% | Jun 2025 |
|
| Aristeia Capital | 320k | $47k | 2% | Sep 2025 |
|
| Linden Advisors | 268k | $40k | 0% | Sep 2025 |
|
| Saba Capital Management | 234k | $35k | 0% | Sep 2025 |
|
| Highbridge Capital Management | 144k | $17k | 8% | Sep 2025 |
|
| Moore Capital Management | 125k | $19k | 0% | Sep 2025 |
|
| Polar Securities | 123k | $18k | 0% | Sep 2025 |
|
| MMCAP International Inc. SPC | 112k | $17k | 0% | Sep 2025 |
|
| Nomura Holdings | 97k | $12k | 100% | Sep 2025 |
|
| Falcon Edge Capital | 89k | $11k | 0% | Sep 2025 |
|
| D. E. Shaw & Co | 83k | $10k | 0% | Sep 2025 |
|
| Millennium Management | 71k | $10k | 0% | Sep 2025 |
|
| Wolverine Asset Management | 63k | $9.3k | -39% | Sep 2025 |
|
| Blue Owl Capital Holdings | 50k | $7.4k | 0% | Sep 2025 |
|
| Periscope Capital | 48k | $7.0k | -5% | Sep 2025 |
|
| Toronto-Dominion Bank | 35k | $5.2k | 0% | Sep 2025 |
|
| Gts Securities | 30k | $4.4k | 100% | Sep 2025 |
|
| LMR Partners | 30k | $4.4k | 0% | Sep 2025 |
|
| Arena Capital Advisors, LLC- CA | 29k | $4.3k | 0% | Sep 2025 |
|
| Jane Street | 24k | $3.6k | -9% | Sep 2025 |
|
| Limestone Investment Advisors | 23k | $3.3k | 100% | Sep 2025 |
|
| Cubist Systematic Strategies | 16k | $2.3k | 0% | Sep 2025 |
|
| Meteora Capital | 15k | $2.2k | 0% | Sep 2025 |
|
| Flow Traders US | 13k | $2.0k | 0% | Sep 2025 |
|
| DuPont Capital Management Corporation | 6.3k | $925.000000 | 0% | Sep 2025 |
|
| HGC Investment Management | 1.3k | $185.000000 | 0% | Sep 2025 |
|
| UBS Group | 290.00 | $43.007000 | -86% | Sep 2025 |
|
Who sold out of Liminatus Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Cantor Fitzgerald, L. P. | Jun 2025 | 876k | $210k |